SKYA vs STVN vs BAX Stock Comparison

SkyAI, Stevanato Group S.p.A and Baxter International Prices as of Oct 27, 2026 Peers: Industry group
SKYA SkyAI, Inc.
$2.91 +54.8% 1M -46.2% 1Y
Market cap
$209.79M
P/E
–
Revenue (TTM)
$194.22K
Div. yield
–
Medical Supplies Healthcare
2 wins
STVN Stevanato Group S.p.A.
$19.61 -7.5% 1M -24.5% 1Y
Market cap
$5.94B
P/E
34.1x
Revenue (TTM)
$1.43B
Div. yield
0.25%
Medical Supplies Healthcare
6 wins
BAX Baxter International Inc
$24.92 +6.6% 1M +7.6% 1Y
Market cap
$12.88B
P/E
–
Revenue (TTM)
$5.55B
Div. yield
0.16%
Medical Supplies Healthcare
3 wins

Head to Head

11 decided of 12

Stevanato Group S.p.A leads on 6 of the 12 questions below (Stevanato Group S.p.A 6, Baxter International 3, SkyAI 2). Which ones matter depends on what you are buying for; a cheap multiple and slow growth often come together.

QuestionSKYASTVNBAXLeader
Larger companyMarket capitalisation $209.79M $5.94B $12.88B BAX
Cheaper on earningsLower P/E, profitable companies only -0.7x 34.1x -12.1x –
Cheaper on forward earningsLower price / next fiscal year consensus EPS 0.0x 29.7x 12.6x SKYA
Faster revenue growthRevenue growth, trailing twelve months +108.9% +14.8% -49.1% SKYA
More profitableNet margin, trailing twelve months -158,431.4% 11.0% -19.2% STVN
Better return on capitalReturn on invested capital — 7.2% 3.4% STVN
Less leveragedLower net debt / EBITDA — 1.2x 4.8x STVN
Higher dividend yieldTrailing dividend yield — 0.25% 0.16% STVN
Better 1-year returnPrice return, last 12 months -46.2% -24.5% +7.6% BAX
Better 5-year returnAnnualised price return, 5 years — -5.1%/yr -20.5%/yr STVN
Less volatileAnnualised volatility, 1 year 106.0% 45.6% 44.3% BAX
Higher overall scoreMean of the five percentile scores vs peers 26/100 67/100 44/100 STVN

Percentile Scorecard

SKYASTVNBAX

Each axis is the mean percentile of its metrics against the company's industry group. 100 is the best in the group, 50 the middle.

Scores by Axis

AxisSKYASTVNBAX
Valuation 2 #222 of 227 81 #44 of 227 83 #40 of 227
Growth 6 #205 of 219 58 #92 of 219 19 #177 of 219
Profitability 1 #204 of 206 82 #39 of 206 72 #58 of 206
Financial Health 95 #14 of 238 72 #68 of 238 19 #193 of 238
Shareholder Returns – 41 #80 of 134 26 #99 of 134
Overall 26 67 44
  • SKYA ranked among 247 companies in Medical Devices and Diagnostics
  • STVN ranked among 247 companies in Medical Devices and Diagnostics
  • BAX ranked among 247 companies in Medical Devices and Diagnostics

Price Performance

Price return, split-adjusted, before dividends. Click a name to hide or show it.

Returns

PeriodSKYASTVNBAXSPY
1 month +54.8%-7.5%+6.6% -0.2%
3 months +107.9%-2.6%+2.3% +3.9%
6 months +62.6%+21.0%+38.9% +8.2%
Year to date +43.3%-2.5%+30.4% +12.9%
1 year -46.2%-24.5%+7.6% +12.3%
3 years -99.9%-31.7%-22.5% +87.4%
3 years, per year -90.1%-12.0%-8.2% +23.3%
5 years —-23.2%-68.3% +67.9%
5 years, per year —-5.1%-20.5% +10.9%
10 years ——-46.8% +261.1%
10 years, per year ——-6.1% +13.7%

Risk

MeasureSKYASTVNBAXSPY
Volatility, 1Y 106.0%45.6%44.3% 12.7%
Downside volatility, 1Y 104.5%44.7%48.0% 12.7%
Beta vs S&P 500, 1Y 2.591.121.16 1.00
Return / volatility, 1Y -0.44-0.540.17 0.97
Max drawdown, 5Y -100.0%-62.2%-82.3% -25.4%
From 52-week high -46.2%-24.5%-12.1% -1.2%
52-week high $5.41$25.98$28.35 $779.14
52-week low $0.95$13.43$15.80 $631.97

Valuation History

Weekly multiples on trailing twelve-month fundamentals. Negative or extreme readings (a loss year, a collapsed denominator) are left out so the chart stays readable.

MultipleSKYASTVNBAX
P/E now vs peer median -0.7xmedian 29.6x 34.1xmedian 29.6x -12.1xmedian 29.6x
P/S now vs peer median 1,080xmedian 2.9x 4.2xmedian 2.9x 2.3xmedian 2.9x
EV/EBITDA now vs peer median —median 17.4x 18.4xmedian 17.4x 13.4xmedian 17.4x
P/FCF now vs peer median —median 22.3x 10.0xmedian 22.3x 15.4xmedian 22.3x
P/B now vs peer median 1.3xmedian 2.3x 3.4xmedian 2.3x 2.1xmedian 2.3x
PEG now vs peer median 0.01median 1.04 -127.14median 1.04 -0.42median 1.04

Financial History

Reported figures by fiscal period, placed on the calendar year (or quarter) each period ended in, so companies with different fiscal years line up.

Trailing twelve monthsSKYASTVNBAX
Revenue $194.22K $1.43B $5.55B
Gross profit $321.93K $416.82M $3.78B
Operating income -$289.52M $233.97M $532.00M
Net income -$307.71M $157.06M -$1.06B
Free cash flow – $592.88M $839.00M
R&D $399.91K $29.75M $542.00M
EPS (diluted) $-4.27 $0.58 $-2.05
Cash & equivalents $12.07M $89.82M $2.15B
Total debt – $2.11B $9.46B
Shares (diluted) 72.09M 272.96M 518.00M
Enterprise value $168.49M $5.38B $4.99B

All Metrics

58 metrics · best in bold

Bold marks the best reading: the lowest positive value for multiples, leverage and payout, the highest for everything else. The bar under each value is its percentile against that company's own peers. Hover a value for its rank and the peer median.

Valuation

12 metrics
MetricSKYASTVNBAX
P/E -0.7x 34.1x -12.1x
P/FCF – 10.0x 15.4x
P/Operating cash flow – 20.5x 9.6x
P/S 1,080x 4.2x 2.3x
P/B 1.3x 3.4x 2.1x
P/Tangible book 16.1x 3.4x 6.0x
EV/EBITDA – 18.4x 13.4x
EV/EBIT -0.7x 27.1x 38.0x
EV/Revenue 1,018x 4.4x 3.6x
EV/FCF – 10.7x 24.1x
EV/Operating cash flow – 21.9x 15.0x
PEG (3Y EPS CAGR) 0.01 -127.14 -0.42

Growth

14 metrics
MetricSKYASTVNBAX
Revenue growth (1Y) 108.9% 14.8% -49.1%
Revenue CAGR (3Y) 23.8% 9.8% -23.5%
Gross profit growth (1Y) – 19.4% -1.8%
Gross profit CAGR (3Y) – 6.2% -5.2%
Operating income growth (1Y) -5,525% 17.2% -50.8%
Operating income CAGR (3Y) -212.8% 4.5% 29.5%
Net income growth (1Y) -42,440% 7.5% -604.0%
Net income CAGR (3Y) -238.0% 0.8% 28.0%
EPS growth (1Y) -487.2% 6.7% -580.5%
EPS CAGR (3Y) -84.2% -0.3% 28.6%
Operating cash flow growth (1Y) – 30.4% 56.3%
Operating cash flow CAGR (3Y) – 32.9% -4.8%
Free cash flow growth (1Y) – 17.2% 153.5%
Free cash flow CAGR (3Y) – 8.0% -9.5%

Profitability

14 metrics
MetricSKYASTVNBAX
Gross margin 165.8% 29.2% 68.1%
EBITDA margin – 24.1% 27.3%
Operating margin -149,065% 16.4% 9.6%
Pretax margin -151,352% 15.7% 5.1%
Net margin -158,431% 11.0% -19.2%
FCF margin – 41.5% 15.1%
Operating cash flow margin – 20.3% 24.2%
Return on equity -140.2% 8.9% -17.4%
Return on assets -137.6% 5.3% -5.4%
Return on invested capital – 7.2% 3.4%
Return on capital employed -136.7% – 3.3%
Asset turnover 0.0x 0.5x 0.3x
Cash conversion (OCF / net income) – 1.8x -1.3x
Stock comp / revenue 48,037% – 2.1%

Financial Health

11 metrics
MetricSKYASTVNBAX
Debt / assets – 17.0% 47.8%
Debt / equity – 0.3x 1.5x
Net debt / EBITDA – 1.2x 4.8x
Debt / FCF – 0.9x 11.3x
Liabilities / assets 1.9% 40.8% 68.6%
Equity / assets 98.1% 59.2% 31.4%
Interest coverage – 14.9x –
Current ratio 5.3x – 1.9x
Quick ratio 4.4x – 1.1x
Cash ratio 4.2x – 0.6x
Altman Z-score 31.41 – 2.12

Shareholder Returns

7 metrics
MetricSKYASTVNBAX
Dividend yield – 0.3% 0.2%
Net buyback yield – – -0.2%
Shareholder yield – 0.3% 0.0%
Payout ratio (earnings) – – -17.3%
Payout ratio (FCF) – – 21.9%
Dividend growth (1Y) – – -60.8%
Dividend CAGR (3Y) – – -32.0%

Analyst Estimates

Solid lines are reported fiscal-year results; dashed lines are the consensus for the years ahead. Hover a year for the analysts' high and low, and how each result compared with its estimate.

ConsensusSKYASTVNBAX
Forward P/E 0.0xFY2026 29.7xFY2026 12.6xFY2026
EPS, next fiscal year $2,362.06FY2026 $0.66FY2026 $1.98FY2026
EPS growth, next FY – +4.8%FY2026 -10.4%FY2026
EPS growth, the year after – +15.2% -3.5%
Revenue, next fiscal year $70.01MFY2026 $1.46BFY2026 $11.05BFY2026
Revenue growth, next FY +34,200.1%FY2026 +5.1%FY2026 -1.7%FY2026
Revenue growth, the year after +17.5% +10.0% +11.7%

Institutional Ownership

13F filings, quarter ended Jun 30, 2026
HoldersSKYASTVNBAX
Held by institutions – 16.4% 100.0%
Institutions holding – 126 690
Change in shares held, QoQ – +0.4% +5.2%
Institutions buying – 61 359
Institutions selling – 52 193
Buyers to sellers – 1.17 1.86

Return Correlation

Daily returns, last 12 months

1.00 means two stocks move in lockstep, 0 that they move independently. Pairs below about 0.5 diversify each other.

SKYASTVNBAX
SKYA 1.00 0.14 0.11
STVN 0.14 1.00 0.20
BAX 0.11 0.20 1.00

Add a Peer

Largest companies in the same industry

Related Comparisons

Frequently Asked Questions

Which is bigger, SKYA, STVN and BAX?

Baxter International (BAX) is the largest by market capitalisation: SkyAI (SKYA) $209.79M, Stevanato Group S.p.A (STVN) $5.94B, Baxter International (BAX) $12.88B.

Which company is growing faster?

SkyAI (SKYA) grew revenue fastest over the trailing twelve months: SkyAI (SKYA) +108.9%, Stevanato Group S.p.A (STVN) +14.8%, Baxter International (BAX) -49.1%.

Which company is more profitable?

Stevanato Group S.p.A (STVN) has the highest net margin (SkyAI (SKYA) -158,431.4%, Stevanato Group S.p.A (STVN) 11.0%, Baxter International (BAX) -19.2%). On return on invested capital, Stevanato Group S.p.A (STVN) leads (Stevanato Group S.p.A (STVN) 7.2%, Baxter International (BAX) 3.4%).

Which stock has performed better?

Over the past year Baxter International (BAX) returned the most: SkyAI (SKYA) -46.2%, Stevanato Group S.p.A (STVN) -24.5%, Baxter International (BAX) +7.6%. Over five years, Stevanato Group S.p.A (STVN) compounded fastest (Stevanato Group S.p.A (STVN) -5.1%/yr, Baxter International (BAX) -20.5%/yr). Returns are price only, before dividends.

Which pays a higher dividend?

Stevanato Group S.p.A (STVN) has the highest dividend yield: Stevanato Group S.p.A (STVN) 0.25%, Baxter International (BAX) 0.16%. SkyAI (SKYA) pays no regular dividend.

Which stock is riskier?

By one-year price volatility, Baxter International (BAX) has been the steadiest (SkyAI (SKYA) 106.0%, Stevanato Group S.p.A (STVN) 45.6%, Baxter International (BAX) 44.3%). Volatility measures how widely the price swings, not the risk of the business.

Which is the better stock, SKYA, STVN and BAX?

There is no single answer; it depends on what you are buying for. On the 12 head-to-head measures on this page, Stevanato Group S.p.A (STVN) leads on 6. Business Quant does not give investment advice; use the comparison as a starting point for your own research.

Data from SEC filings, exchange prices and consensus estimates, via Business Quant. Percentile scores compare each company with its own peer group, so two companies' scores are each relative to different peers unless you rank against the whole market. Price returns exclude dividends. Nothing on this page is investment advice.